METABOLIC SYNDROME AMONG STROKE PATIENTS IN DUHOK/ KURDISTAN/ IRAQ
Background: The metabolic syndrome is a highly prevalent disorder of various vascular risk factors including obesity, hypertension, diabetes mellitus, and hyper lipidaemia. The disorder has been well associated with cerebral stroke and heart disease. Since a former study of risk factors among hospitalized stroke patients had been done in Duhok, this study has been designed to assess the presence of metabolic syndrome among those stroke victims.
Patients and Methods: The study reassessed a previous case series study comprising 950 patients who presented with stroke and were admitted to the Neurology Ward at Azadi Teaching Hospital/Duhok, between January 2014-December 2014. Only 392 patients(41.3%) were found to satisfy the criteria of metabolic syndrome and therefore included in this study; they came from Duhok City and many other cities and towns around including Nineveh Governorate. A suitable format sheet had been designed to document data from the relevant records. Data were analyzed using one sample z test of proportion and Chi square test. A p ≤ 0.05 was considered significant.
Results: Out of the studied 950 patients, only 392patients; 254females (64.8%) and 138males(35.2%)were found to have at least three or more risk factors of the Metabolic Syndrome. Ages for males and females ranged from 26-98years, (65.1±12.9) and35-105(64.5±12.1) respectively. The patients were multiethnic and the most frequent risk factors, in a decreasing frequency, were obesity/overweight 373 (95.2%), hypertension323 (82.4%), diabetes mellitus273 (69.6%), and hyperlipidaemia200 (51%).The majority of cases were of the ischemic type, 337 (86%).
Conclusions: In reference to the general population, the prevalence of MetS among Cerebral Stroke sufferers is high especially among females with relatively high prevalence of ischemic strokes in both genders.
2. Kylin E. Studies of the hypertension-hyperglycemia-hyperuricemia syndrome (German) Zentralbl Inn Med.1923; 44:105–27.
3. Vague J. Sexual differentiation: A factor affecting the forms of obesity. Presse Med. 1947; 30:339–40.
4. Chakraborty SN, Roy SK, Rahaman MA. Epidemiological predictors of metabolic syndrome in urban West Bengal, India.J Family Med Prim Care. 2015 Oct-Dec; 4(4):535-8.
5. Adediran OS, Jimoh AK, Ogbera AO. Metabolic syndrome: The pathogenesis of its predictors. Postgrad Doctor Caribbean. 2006; 22:35–45.
6. Mufunda J, Sigola LB, Chifamba J, Vengesa PM. Hyperinsulinemia: Possible cause of high blood pressure in unemployed urban black women. High Blood Pressure. 1995; 4:137–40.
7. Neel JV. Diabetes mellitus: A ‘thrifty’ genotype rendered detrimental by ‘progress’? Am J Hum Genet. 1962;14:353–62.
8. Levitt NS, Lambert EV. The foetal origins of the metabolic syndrome: A South African perspective. Cardiovasc J S Afr. 2002;13:179–80.
9. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004; 350:2362–74.
10. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: Findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med. 2003;157:821–7.
11. Cruz ML, Weigensberg MJ, Huang TT, Ball G, Shaibi GQ, Goran MI. The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity J Clin Endocrinol Metab. 2004 Jan 89(1):108–13.
12. Tørris C, Molin M, Cvancarova Småstuen M. .Associations between fish consumption and metabolic syndrome. A large cross-sectional study from the Norwegian Tromsø Study: Tromsø 4. Diabetol MetabSyndr. 2016; 8: 18.
13. Lee H, and Kim B. Physical activity disparities by socioeconomic status among metabolic syndrome patients: The Fifth Korea National Health and Nutrition Examination Survey. J Exerc Rehabil. 2016 Feb; 12(1): 10–14.
14. Jahangiry L, Shojaeezadeh D, Montazeri A, Najafi M, and Mohammad K. Health-related Quality of Life Among People Participating in a Metabolic Syndrome E-screening Program: A Web-based Study. Int J Prev Med. 2016; 7: 27.
15. Esposito K, Chiodini P, Colao A, Lenzi A, and Giugliano D. Metabolic Syndrome and Risk of Cancer: A systematic review and meta-analysis. Diabetes Care. 2012 Nov; 35(11): 2402–2411
16. Wong YV, Cook P,and Somani B K. Association of Metabolic Syndrome and Urolithiasis. Int J Endocrinol. 2015; 2015: 570-674.
17. TadewosHirigo A and TesfayeDY. Influences of gender in metabolic syndrome and its components among people living with HIV virus using antiretroviral treatment in Hawassa, southern Ethiopia.BMC Res Notes.2016; 9: 145.
18. Bernadette B, Sacco R L. , Lee H, Grahame-Clarke C, Rundek T, Elkind M V. et al. Metabolic Syndrome and Ischemic Stroke Risk Northern Manhattan Study. Stroke. 2008 Jan; 39(1): 30–35.
19. Brola W, Sobolewski P, Fudala M, Goral A, Kasprzyk M, Szczuchniak W, et al. Metabolic Syndrome in Polish Ischemic Stroke Patients.J Stroke Cerebrovasc Dis. 2015 Sep; 24(9): 2167-72.
20. Christian I. Okafor. The metabolic syndrome in Africa: Current trends. Indian J Endocrinol Metab. 2012 Jan-Feb; 16(1): 56–66.
21. Can AS, Bersot TP. Analysis of agreement among definitions of metabolic syndrome in nondiabetic Turkish adults: A methodological study. BMC Public Health. 2007; 7: 353.
22. MOH, WHO. Non-communicable Diseases Risk Factor Survey in Iraq: A STEP wise Approach. Draft report; 2015
23. BachirCherif A, Temmar M, Chibane A, Labat C, Atif ML, Taleb A, et al. The metabolic syndrome in hypertensive black population of South Algeria.Ann Cardiol Angeiol (Paris). 2015 Jun;64(3):158-63.
24. Isezuo SA, Ezunu E. Demographic and clinical correlates of metabolic syndrome in native African type 2 diabetic patients. J Natl Med Assoc. 2005;97:557–63.
25. AlSaraj F, McDermott JH, Cawood T, McAteer S, Ali M, Tormey W, et al. Prevalence of the metabolic syndrome in patients diabetes mellitus. Ir J Med Sc. 2009;178:309–13.
26. Wahab KW, Sani M, Gbadamosi M, Yandutse M. Frequency and determinants of the metabolic syndrome in apparently healthy adult Nigerians. Trop Doct. 2008;38:224–6.
27. Vorster HH. The emergence of cardiovascular disease during urbanization of Africans. Public Health Nutr. 2002;5:239–43.
28. Ulasi II, Ijoma CK, Onodugo OD. A community-based study of hypertension and cardio-metabolic syndrome in semi-urban and rural communities in Nigeria. BMC Health Serv Res. 2010;10:71.
29. Njelekela MA, Mpembeni R, Muhihi A, Mligiliche NL, Spiegelman D, Hertzmark E, et al. Gender-related differences in the prevalence of cardiovascular disease risk factors and their correlates in urban Tanzania. BMC Cardiovasc Disord. 2009; 9:30.
30. Liu L, Zhan L, Wang Y, Bai C, Guo J, Lin Q, et al.. Metabolic syndrome and the short-term prognosis of acute ischemic stroke: a hospital-based retrospective study. Lipids Health Dis. 2015; 14: 76.
31. Tran A, Gelaye B, Girma B, Lemma S, Berhane Y, Bekele T, et al. Prevalence of metabolic syndrome among working adults in ethiopia. Int J Hypertens. 2011:193719.
32. Sodjinou R, Agueh V, Fayomi B, Delisle H. Obesity and cardiometabolic risk factors in urban adults of Benin: Relationship with socio-economic status, urbanisation, and lifestyle Patterns.BMC Public Health. 2008; 8:84.
33. Van der Sande MA, Ceesay SM, Milligan PJ, Nyan OA, Banya WA, Prentice A, et al. Obesity and under nutrition and cardiovascular risk factors in rural and urban gambian communities. Am J Public Health. 2001;91:1641–4.
34. Smith C, FaadielEssop M. Gender differences in metabolic risk factor prevalence in a South African student population. Cardiovasc J Afr. 2009;20:178–82.
35. BeLue R, Okoror TA, Iwelunmor J, Taylor KD, Degboe AN, Agyemang C, et al. An overview of cardiovascular risk factor burden in sub-Saharan African countries: A socio-cultural perspective. Global Health. 2009;5:10.
36. Puepet FH, Uloko A, Akogu IY, Aniekwensi E. Prevalence of the metabolic syndrome among patients with type 2 diabetes mellitus in urban North-Central Nigeria. Afr J Endocrinol Metab. 2009;8:10–2.